Paul Thomas is Director of Axogen, Inc.. Currently has a direct ownership of 34,927 shares of AXGN, which is worth approximately $465,926. The most recent transaction as insider was on Sep 16, 2024, when has been sold 2,875 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.9K
73.35% 3M change
267.85% 12M change
Total Value Held $465,926

PAUL THOMAS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2024
BUY
Grant, award, or other acquisition
-
2,875 Added 7.61%
34,927 Common Stock
Sep 01 2024
BUY
Exercise of conversion of derivative security
-
11,904 Added 27.08%
32,052 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
10,653 Added 34.59%
20,148 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
6,459 Added 40.49%
9,495 Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
3,036 Added 50.0%
3,036 Common Stock

Also insider at

SRGA
SURGALIGN HOLDINGS, INC. Healthcare
ABMD
ABIOMED INC Healthcare
PT

Paul Thomas

Director
Danvers, MA

Track Institutional and Insider Activities on AXGN

Follow Axogen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

News

Receive news related to Axogen, Inc.

Track Activities on AXGN